Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT07463677 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07463677
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-15
- Primary completion
- 2028-05-31
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.